CST3 and chronic kidney disease: This is consistent with data from NHANES in the US showing that the prevalence of elevated cystatin C levels increased dramatically with age, with over 50% of those older than 80 having elevated levels.[21] Analyses of CKD prevalence trends in NHANES suggest higher prevalence of CKD G3–5 derived from cystatin C than from creatinine based equations.[33]